Markers of Kidney Injury, Inflammation, and Fibrosis Associated With Ertugliflozin in Patients With CKD and DiabetesHongyan Liu, David Z.I. Cherney, Davor Brinc et al.|Kidney International Reports|2021Cited by 44
A Bayesian network meta-analysis of non-pharmacological interventions for neonatal pain management: a clinical effectiveness comparisonLimei Xu, Bo Zheng, Yuwei Hu et al.|Frontiers in Pediatrics|2025Cited by 2
Cardio-Kidney Effects of Dapagliflozin in Patients at Elevated Cardiovascular Risk with or Without Type 2 DiabetesVikas S. Sridhar, David Z.I. Cherney, Luxcia Kugathasan et al.|Journal of the American Society of Nephrology|2025Cited by 0